The cell-free RNA isolation and extraction kits market is a well-developed market with an integral part of medical decision-making -aid in acquiring information for a wide range of treatment dissemination, accentuating their criticality in healthcare.
The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032. The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers offering cell-free RNA analysis.
Impact of COVID-19
The current global cell-free RNA isolation and extraction kits market study comprises cell-free RNA isolation and extraction kits that are used to extract and isolate cell-free RNA form samples collected from patients and preserve cell-free RNA for further downstream analysis to retrieve actionable information from it. Since the market is primarily dominated by the manufacturers of cell-free RNA isolation and extraction kits, the pandemic had a negative impact on the growth of revenue generated from the market. Players in the cell-free RNA isolation and extraction kits market reported a decline in revenues during the initial phase of the pandemic.
The decline was primarily attributed to the lockdown in the regions that disrupted the supply chain, thereby hampering the cancer diagnostic testing. Additionally, a halt in research and development activities pertaining to cell-free RNA for oncology, prenatal screening, and metabolic disorders market also led to a decline in revenue. Moreover, in order to curb the spread of the SARS-CoV-2 virus, and contain the spread of the virus, demand for COVID-19 tests and services that detects the virus in less time increased, which led to the shift in focus of the manufacturers for developing and manufacturing testing kits and services for the detection of SARS-CoV-2 virus.
Recent Developments in Global Cell-Free RNA Isolation and Extraction Kits Market
• In February 2022, Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems.
• In February 2019, Norgen Biotek Corp. introduced the cf-DNA / cf-RNA Preservative Tubes for long-term storage of blood. These are more suitable blood collection tubes (BCTs) as compared to other competitor’s blood collection tubes (BCTs) in the cell-free RNA market. This is the only product that keeps both cf-DNA and cf-RNA in the same tube for 30 days, allowing researchers to examine both genomics and transcriptomics.
Market Segmentation:
Segmentation 1: by Application
• Oncology
• Prenatal Screening (Preeclampsia)
• Metabolic Disorders
The oncology segment accounted for the largest share of 79.85% in the global cell-free RNA isolation and extraction kits market in 2021.
Segmentation 2: by End User
• Hospitals
• Academic Research Institutions and Laboratories
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
The academic research institutions and laboratories segment accounted for the largest share of 63.13% in the global cell-free RNA isolation and extraction kits market in FY2021.
Segmentation 3: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World
North America cell-free RNA isolation and extraction market dominated the global cell-free RNA isolation and extraction kits market and is expected to maintain its dominance over other regions throughout the forecast period 2022-2032.
Demand – Drivers and Limitations
Following are the demand drivers for the Global Cell-Free RNA Isolation and Extraction Kits Market:
• Increasing Incidence of Cancer
• Increasing Number of Cases with Prenatal Complications
• Advancement in the RNA Sequencing Technology
The market is expected to face some limitations too due to the following challenges:
• Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
• Ethical, Legal, and Social Issues Associated with Prenatal Screening
Get Free Sample Report - https://bisresearch.com/requestsample?id=1355type=download
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
The leading top segment players include cell-free RNA isolation and extraction kits manufacture in year 2021 that caters to different area of application that includes oncology, prenatal screening, and metabolic disorders.
Some of the prominent names established in this market are:
• Aline Biosciences
• Apostle Sciences
• Danagen-Bioted, S.L.
• F. Hoffmann-La Roche Ltd.
• JBS Science Inc.
• Norgen Biotek Corp.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Streck, Inc.
• Thermo Fisher Scientific Inc.
• Takara Bio Inc.
• Zymo Research Corporation
Key Questions Answered in the Report
- How is the cell-free RNA isolation and extraction kits
- market revolutionizing oncology, prenatal screening, and metabolic disorders’ landscapes?
- What are the major market drivers, challenges, and opportunities in the global cell-free RNA isolation and extraction kits market?
- What are the underlying structures resulting in the emerging trends within the cell-free RNA isolation and extraction kits market?
- What are the key development strategies that are being implemented by major players to sustain themselves in the market?
- What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free RNA products and services?
BIS Related Studies
Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis
